Repotrectinib Post-Marketing Surveillance in Pediatric Patients With NTRK Fusion-Positive Tumors in Japan

Clinical trial NCT07755826 · RECRUITING

Trial details

NCT number: NCT07755826
Sponsor: Bristol-Myers Squibb
Status: RECRUITING
Study type: OBSERVATIONAL

NTRK Fusion-positive Solid Tumors

Start date: 2025-11-20
Primary completion: 2034-04-30
Enrollment: 20

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.